Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Anti-diabetes Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Liquid
1.2.3 Capsule
1.2.4 Tablet
1.3 Market by Application
1.3.1 Global Oral Anti-diabetes Drugs Market Share by Distribution Channel: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Oral Anti-diabetes Drugs Market Perspective (2016-2027)
2.2 Oral Anti-diabetes Drugs Growth Trends by Regions
2.2.1 Oral Anti-diabetes Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Oral Anti-diabetes Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Oral Anti-diabetes Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Oral Anti-diabetes Drugs Industry Dynamic
2.3.1 Oral Anti-diabetes Drugs Market Trends
2.3.2 Oral Anti-diabetes Drugs Market Drivers
2.3.3 Oral Anti-diabetes Drugs Market Challenges
2.3.4 Oral Anti-diabetes Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Oral Anti-diabetes Drugs Players by Revenue
3.1.1 Global Top Oral Anti-diabetes Drugs Players by Revenue (2016-2021)
3.1.2 Global Oral Anti-diabetes Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Oral Anti-diabetes Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Oral Anti-diabetes Drugs Revenue
3.4 Global Oral Anti-diabetes Drugs Market Concentration Ratio
3.4.1 Global Oral Anti-diabetes Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Anti-diabetes Drugs Revenue in 2020
3.5 Oral Anti-diabetes Drugs Key Players Head office and Area Served
3.6 Key Players Oral Anti-diabetes Drugs Product Solution and Service
3.7 Date of Enter into Oral Anti-diabetes Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Oral Anti-diabetes Drugs Breakdown Data by Type
4.1 Global Oral Anti-diabetes Drugs Historic Market Size by Type (2016-2021)
4.2 Global Oral Anti-diabetes Drugs Forecasted Market Size by Type (2022-2027)

5 Oral Anti-diabetes Drugs Breakdown Data by Distribution Channel
5.1 Global Oral Anti-diabetes Drugs Historic Market Size by Distribution Channel (2016-2021)
5.2 Global Oral Anti-diabetes Drugs Forecasted Market Size by Distribution Channel (2022-2027)

6 North America
6.1 North America Oral Anti-diabetes Drugs Market Size (2016-2027)
6.2 North America Oral Anti-diabetes Drugs Market Size by Type
6.2.1 North America Oral Anti-diabetes Drugs Market Size by Type (2016-2021)
6.2.2 North America Oral Anti-diabetes Drugs Market Size by Type (2022-2027)
6.2.3 North America Oral Anti-diabetes Drugs Market Size by Type (2016-2027)
6.3 North America Oral Anti-diabetes Drugs Market Size by Distribution Channel
6.3.1 North America Oral Anti-diabetes Drugs Market Size by Distribution Channel (2016-2021)
6.3.2 North America Oral Anti-diabetes Drugs Market Size by Distribution Channel (2022-2027)
6.3.3 North America Oral Anti-diabetes Drugs Market Size by Distribution Channel (2016-2027)
6.4 North America Oral Anti-diabetes Drugs Market Size by Country
6.4.1 North America Oral Anti-diabetes Drugs Market Size by Country (2016-2021)
6.4.2 North America Oral Anti-diabetes Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Oral Anti-diabetes Drugs Market Size (2016-2027)
7.2 Europe Oral Anti-diabetes Drugs Market Size by Type
7.2.1 Europe Oral Anti-diabetes Drugs Market Size by Type (2016-2021)
7.2.2 Europe Oral Anti-diabetes Drugs Market Size by Type (2022-2027)
7.2.3 Europe Oral Anti-diabetes Drugs Market Size by Type (2016-2027)
7.3 Europe Oral Anti-diabetes Drugs Market Size by Distribution Channel
7.3.1 Europe Oral Anti-diabetes Drugs Market Size by Distribution Channel (2016-2021)
7.3.2 Europe Oral Anti-diabetes Drugs Market Size by Distribution Channel (2022-2027)
7.3.3 Europe Oral Anti-diabetes Drugs Market Size by Distribution Channel (2016-2027)
7.4 Europe Oral Anti-diabetes Drugs Market Size by Country
7.4.1 Europe Oral Anti-diabetes Drugs Market Size by Country (2016-2021)
7.4.2 Europe Oral Anti-diabetes Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Oral Anti-diabetes Drugs Market Size (2016-2027)
8.2 Asia-Pacific Oral Anti-diabetes Drugs Market Size by Type
8.2.1 Asia-Pacific Oral Anti-diabetes Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Oral Anti-diabetes Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Oral Anti-diabetes Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Oral Anti-diabetes Drugs Market Size by Distribution Channel
8.3.1 Asia-Pacific Oral Anti-diabetes Drugs Market Size by Distribution Channel (2016-2021)
8.3.2 Asia-Pacific Oral Anti-diabetes Drugs Market Size by Distribution Channel (2022-2027)
8.3.3 Asia-Pacific Oral Anti-diabetes Drugs Market Size by Distribution Channel (2016-2027)
8.4 Asia-Pacific Oral Anti-diabetes Drugs Market Size by Region
8.4.1 Asia-Pacific Oral Anti-diabetes Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Oral Anti-diabetes Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Oral Anti-diabetes Drugs Market Size (2016-2027)
9.2 Latin America Oral Anti-diabetes Drugs Market Size by Type
9.2.1 Latin America Oral Anti-diabetes Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Oral Anti-diabetes Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Oral Anti-diabetes Drugs Market Size by Type (2016-2027)
9.3 Latin America Oral Anti-diabetes Drugs Market Size by Distribution Channel
9.3.1 Latin America Oral Anti-diabetes Drugs Market Size by Distribution Channel (2016-2021)
9.3.2 Latin America Oral Anti-diabetes Drugs Market Size by Distribution Channel (2022-2027)
9.3.3 Latin America Oral Anti-diabetes Drugs Market Size by Distribution Channel (2016-2027)
9.4 Latin America Oral Anti-diabetes Drugs Market Size by Country
9.4.1 Latin America Oral Anti-diabetes Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Oral Anti-diabetes Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Oral Anti-diabetes Drugs Market Size (2016-2027)
10.2 Middle East & Africa Oral Anti-diabetes Drugs Market Size by Type
10.2.1 Middle East & Africa Oral Anti-diabetes Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Oral Anti-diabetes Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Oral Anti-diabetes Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Oral Anti-diabetes Drugs Market Size by Distribution Channel
10.3.1 Middle East & Africa Oral Anti-diabetes Drugs Market Size by Distribution Channel (2016-2021)
10.3.2 Middle East & Africa Oral Anti-diabetes Drugs Market Size by Distribution Channel (2022-2027)
10.3.3 Middle East & Africa Oral Anti-diabetes Drugs Market Size by Distribution Channel (2016-2027)
10.4 Middle East & Africa Oral Anti-diabetes Drugs Market Size by Country
10.4.1 Middle East & Africa Oral Anti-diabetes Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Oral Anti-diabetes Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Oral Anti-diabetes Drugs Introduction
11.1.4 Sanofi Revenue in Oral Anti-diabetes Drugs Business (2016-2021)
11.1.5 Sanofi Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Oral Anti-diabetes Drugs Introduction
11.2.4 Eli Lilly Revenue in Oral Anti-diabetes Drugs Business (2016-2021)
11.2.5 Eli Lilly Recent Development
11.3 AstraZeneca plc
11.3.1 AstraZeneca plc Company Details
11.3.2 AstraZeneca plc Business Overview
11.3.3 AstraZeneca plc Oral Anti-diabetes Drugs Introduction
11.3.4 AstraZeneca plc Revenue in Oral Anti-diabetes Drugs Business (2016-2021)
11.3.5 AstraZeneca plc Recent Development
11.4 Astellas Pharma Inc
11.4.1 Astellas Pharma Inc Company Details
11.4.2 Astellas Pharma Inc Business Overview
11.4.3 Astellas Pharma Inc Oral Anti-diabetes Drugs Introduction
11.4.4 Astellas Pharma Inc Revenue in Oral Anti-diabetes Drugs Business (2016-2021)
11.4.5 Astellas Pharma Inc Recent Development
11.5 Johnson & Johnson (Janssen Pharmaceuticals)
11.5.1 Johnson & Johnson (Janssen Pharmaceuticals) Company Details
11.5.2 Johnson & Johnson (Janssen Pharmaceuticals) Business Overview
11.5.3 Johnson & Johnson (Janssen Pharmaceuticals) Oral Anti-diabetes Drugs Introduction
11.5.4 Johnson & Johnson (Janssen Pharmaceuticals) Revenue in Oral Anti-diabetes Drugs Business (2016-2021)
11.5.5 Johnson & Johnson (Janssen Pharmaceuticals) Recent Development
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Details
11.6.2 Boehringer Ingelheim Business Overview
11.6.3 Boehringer Ingelheim Oral Anti-diabetes Drugs Introduction
11.6.4 Boehringer Ingelheim Revenue in Oral Anti-diabetes Drugs Business (2016-2021)
11.6.5 Boehringer Ingelheim Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Oral Anti-diabetes Drugs Introduction
11.7.4 Merck Revenue in Oral Anti-diabetes Drugs Business (2016-2021)
11.7.5 Merck Recent Development
11.8 Takeda
11.8.1 Takeda Company Details
11.8.2 Takeda Business Overview
11.8.3 Takeda Oral Anti-diabetes Drugs Introduction
11.8.4 Takeda Revenue in Oral Anti-diabetes Drugs Business (2016-2021)
11.8.5 Takeda Recent Development
11.9 Bristol Myers Squibb
11.9.1 Bristol Myers Squibb Company Details
11.9.2 Bristol Myers Squibb Business Overview
11.9.3 Bristol Myers Squibb Oral Anti-diabetes Drugs Introduction
11.9.4 Bristol Myers Squibb Revenue in Oral Anti-diabetes Drugs Business (2016-2021)
11.9.5 Bristol Myers Squibb Recent Development
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Novartis Business Overview
11.10.3 Novartis Oral Anti-diabetes Drugs Introduction
11.10.4 Novartis Revenue in Oral Anti-diabetes Drugs Business (2016-2021)
11.10.5 Novartis Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Details
11.11.2 Pfizer Business Overview
11.11.3 Pfizer Oral Anti-diabetes Drugs Introduction
11.11.4 Pfizer Revenue in Oral Anti-diabetes Drugs Business (2016-2021)
11.11.5 Pfizer Recent Development
11.12 Abbott
11.12.1 Abbott Company Details
11.12.2 Abbott Business Overview
11.12.3 Abbott Oral Anti-diabetes Drugs Introduction
11.12.4 Abbott Revenue in Oral Anti-diabetes Drugs Business (2016-2021)
11.12.5 Abbott Recent Development
11.13 Biocon
11.13.1 Biocon Company Details
11.13.2 Biocon Business Overview
11.13.3 Biocon Oral Anti-diabetes Drugs Introduction
11.13.4 Biocon Revenue in Oral Anti-diabetes Drugs Business (2016-2021)
11.13.5 Biocon Recent Development
11.14 Sunpharma
11.14.1 Sunpharma Company Details
11.14.2 Sunpharma Business Overview
11.14.3 Sunpharma Oral Anti-diabetes Drugs Introduction
11.14.4 Sunpharma Revenue in Oral Anti-diabetes Drugs Business (2016-2021)
11.14.5 Sunpharma Recent Development
11.15 Novo Nordisk
11.15.1 Novo Nordisk Company Details
11.15.2 Novo Nordisk Business Overview
11.15.3 Novo Nordisk Oral Anti-diabetes Drugs Introduction
11.15.4 Novo Nordisk Revenue in Oral Anti-diabetes Drugs Business (2016-2021)
11.15.5 Novo Nordisk Recent Development
11.16 Piramal Healthcare
11.16.1 Piramal Healthcare Company Details
11.16.2 Piramal Healthcare Business Overview
11.16.3 Piramal Healthcare Oral Anti-diabetes Drugs Introduction
11.16.4 Piramal Healthcare Revenue in Oral Anti-diabetes Drugs Business (2016-2021)
11.16.5 Piramal Healthcare Recent Development
11.17 Bayer Healthcare
11.17.1 Bayer Healthcare Company Details
11.17.2 Bayer Healthcare Business Overview
11.17.3 Bayer Healthcare Oral Anti-diabetes Drugs Introduction
11.17.4 Bayer Healthcare Revenue in Oral Anti-diabetes Drugs Business (2016-2021)
11.17.5 Bayer Healthcare Recent Development
11.18 Dr. Reddy’s Laboratories Ltd
11.18.1 Dr. Reddy’s Laboratories Ltd Company Details
11.18.2 Dr. Reddy’s Laboratories Ltd Business Overview
11.18.3 Dr. Reddy’s Laboratories Ltd Oral Anti-diabetes Drugs Introduction
11.18.4 Dr. Reddy’s Laboratories Ltd Revenue in Oral Anti-diabetes Drugs Business (2016-2021)
11.18.5 Dr. Reddy’s Laboratories Ltd Recent Development
11.18 Glenmark Pharmaceuticals Ltd
.1 Glenmark Pharmaceuticals Ltd Company Details
.2 Glenmark Pharmaceuticals Ltd Business Overview
.3 Glenmark Pharmaceuticals Ltd Oral Anti-diabetes Drugs Introduction
.4 Glenmark Pharmaceuticals Ltd Revenue in Oral Anti-diabetes Drugs Business (2016-2021)
.5 Glenmark Pharmaceuticals Ltd Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Oral Anti-diabetes Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Liquid
Table 3. Key Players of Capsule
Table 4. Key Players of Tablet
Table 5. Global Oral Anti-diabetes Drugs Market Size Growth by Distribution Channel (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Oral Anti-diabetes Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Oral Anti-diabetes Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Oral Anti-diabetes Drugs Market Share by Regions (2016-2021)
Table 9. Global Oral Anti-diabetes Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Oral Anti-diabetes Drugs Market Share by Regions (2022-2027)
Table 11. Oral Anti-diabetes Drugs Market Trends
Table 12. Oral Anti-diabetes Drugs Market Drivers
Table 13. Oral Anti-diabetes Drugs Market Challenges
Table 14. Oral Anti-diabetes Drugs Market Restraints
Table 15. Global Oral Anti-diabetes Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Oral Anti-diabetes Drugs Market Share by Players (2016-2021)
Table 17. Global Top Oral Anti-diabetes Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Anti-diabetes Drugs as of 2020)
Table 18. Ranking of Global Top Oral Anti-diabetes Drugs Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Oral Anti-diabetes Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Oral Anti-diabetes Drugs Product Solution and Service
Table 22. Date of Enter into Oral Anti-diabetes Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Oral Anti-diabetes Drugs Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Oral Anti-diabetes Drugs Revenue Market Share by Type (2016-2021)
Table 26. Global Oral Anti-diabetes Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Oral Anti-diabetes Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Oral Anti-diabetes Drugs Market Size Share by Distribution Channel (2016-2021) & (US$ Million)
Table 29. Global Oral Anti-diabetes Drugs Revenue Market Share by Distribution Channel (2016-2021)
Table 30. Global Oral Anti-diabetes Drugs Forecasted Market Size by Distribution Channel (2022-2027) (US$ Million)
Table 31. Global Oral Anti-diabetes Drugs Revenue Market Share by Distribution Channel (2022-2027) & (US$ Million)
Table 32. North America Oral Anti-diabetes Drugs Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Oral Anti-diabetes Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Oral Anti-diabetes Drugs Market Size by Distribution Channel (2016-2021) (US$ Million)
Table 35. North America Oral Anti-diabetes Drugs Market Size by Distribution Channel (2022-2027) & (US$ Million)
Table 36. North America Oral Anti-diabetes Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Oral Anti-diabetes Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Oral Anti-diabetes Drugs Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Oral Anti-diabetes Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Oral Anti-diabetes Drugs Market Size by Distribution Channel (2016-2021) (US$ Million)
Table 41. Europe Oral Anti-diabetes Drugs Market Size by Distribution Channel (2022-2027) & (US$ Million)
Table 42. Europe Oral Anti-diabetes Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Oral Anti-diabetes Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Oral Anti-diabetes Drugs Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Oral Anti-diabetes Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Oral Anti-diabetes Drugs Market Size by Distribution Channel (2016-2021) (US$ Million)
Table 47. Asia-Pacific Oral Anti-diabetes Drugs Market Size by Distribution Channel (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Oral Anti-diabetes Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Oral Anti-diabetes Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Oral Anti-diabetes Drugs Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Oral Anti-diabetes Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Oral Anti-diabetes Drugs Market Size by Distribution Channel (2016-2021) (US$ Million)
Table 53. Latin America Oral Anti-diabetes Drugs Market Size by Distribution Channel (2022-2027) & (US$ Million)
Table 54. Latin America Oral Anti-diabetes Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Oral Anti-diabetes Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Oral Anti-diabetes Drugs Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Oral Anti-diabetes Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Oral Anti-diabetes Drugs Market Size by Distribution Channel (2016-2021) (US$ Million)
Table 59. Middle East & Africa Oral Anti-diabetes Drugs Market Size by Distribution Channel (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Oral Anti-diabetes Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Oral Anti-diabetes Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 62. Sanofi Company Details
Table 63. Sanofi Business Overview
Table 64. Sanofi Oral Anti-diabetes Drugs Product
Table 65. Sanofi Revenue in Oral Anti-diabetes Drugs Business (2016-2021) & (US$ Million)
Table 66. Sanofi Recent Development
Table 67. Eli Lilly Company Details
Table 68. Eli Lilly Business Overview
Table 69. Eli Lilly Oral Anti-diabetes Drugs Product
Table 70. Eli Lilly Revenue in Oral Anti-diabetes Drugs Business (2016-2021) & (US$ Million)
Table 71. Eli Lilly Recent Development
Table 72. AstraZeneca plc Company Details
Table 73. AstraZeneca plc Business Overview
Table 74. AstraZeneca plc Oral Anti-diabetes Drugs Product
Table 75. AstraZeneca plc Revenue in Oral Anti-diabetes Drugs Business (2016-2021) & (US$ Million)
Table 76. AstraZeneca plc Recent Development
Table 77. Astellas Pharma Inc Company Details
Table 78. Astellas Pharma Inc Business Overview
Table 79. Astellas Pharma Inc Oral Anti-diabetes Drugs Product
Table 80. Astellas Pharma Inc Revenue in Oral Anti-diabetes Drugs Business (2016-2021) & (US$ Million)
Table 81. Astellas Pharma Inc Recent Development
Table 82. Johnson & Johnson (Janssen Pharmaceuticals) Company Details
Table 83. Johnson & Johnson (Janssen Pharmaceuticals) Business Overview
Table 84. Johnson & Johnson (Janssen Pharmaceuticals) Oral Anti-diabetes Drugs Product
Table 85. Johnson & Johnson (Janssen Pharmaceuticals) Revenue in Oral Anti-diabetes Drugs Business (2016-2021) & (US$ Million)
Table 86. Johnson & Johnson (Janssen Pharmaceuticals) Recent Development
Table 87. Boehringer Ingelheim Company Details
Table 88. Boehringer Ingelheim Business Overview
Table 89. Boehringer Ingelheim Oral Anti-diabetes Drugs Product
Table 90. Boehringer Ingelheim Revenue in Oral Anti-diabetes Drugs Business (2016-2021) & (US$ Million)
Table 91. Boehringer Ingelheim Recent Development
Table 92. Merck Company Details
Table 93. Merck Business Overview
Table 94. Merck Oral Anti-diabetes Drugs Product
Table 95. Merck Revenue in Oral Anti-diabetes Drugs Business (2016-2021) & (US$ Million)
Table 96. Merck Recent Development
Table 97. Takeda Company Details
Table 98. Takeda Business Overview
Table 99. Takeda Revenue in Oral Anti-diabetes Drugs Business (2016-2021) & (US$ Million)
Table 100. Takeda Recent Development
Table 101. Bristol Myers Squibb Company Details
Table 102. Bristol Myers Squibb Business Overview
Table 103. Bristol Myers Squibb Oral Anti-diabetes Drugs Product
Table 104. Bristol Myers Squibb Revenue in Oral Anti-diabetes Drugs Business (2016-2021) & (US$ Million)
Table 105. Bristol Myers Squibb Recent Development
Table 106. Novartis Company Details
Table 107. Novartis Business Overview
Table 108. Novartis Oral Anti-diabetes Drugs Product
Table 109. Novartis Revenue in Oral Anti-diabetes Drugs Business (2016-2021) & (US$ Million)
Table 110. Novartis Recent Development
Table 111. Pfizer Company Details
Table 112. Pfizer Business Overview
Table 113. Pfizer Oral Anti-diabetes Drugs Product
Table 114. Pfizer Revenue in Oral Anti-diabetes Drugs Business (2016-2021) & (US$ Million)
Table 115. Pfizer Recent Development
Table 116. Abbott Company Details
Table 117. Abbott Business Overview
Table 118. Abbott Oral Anti-diabetes Drugs Product
Table 119. Abbott Revenue in Oral Anti-diabetes Drugs Business (2016-2021) & (US$ Million)
Table 120. Abbott Recent Development
Table 121. Biocon Company Details
Table 122. Biocon Business Overview
Table 123. Biocon Oral Anti-diabetes Drugs Product
Table 124. Biocon Revenue in Oral Anti-diabetes Drugs Business (2016-2021) & (US$ Million)
Table 125. Biocon Recent Development
Table 126. Sunpharma Company Details
Table 127. Sunpharma Business Overview
Table 128. Sunpharma Oral Anti-diabetes Drugs Product
Table 129. Sunpharma Revenue in Oral Anti-diabetes Drugs Business (2016-2021) & (US$ Million)
Table 130. Sunpharma Recent Development
Table 131. Novo Nordisk Company Details
Table 132. Novo Nordisk Business Overview
Table 133. Novo Nordisk Oral Anti-diabetes Drugs Product
Table 134. Novo Nordisk Revenue in Oral Anti-diabetes Drugs Business (2016-2021) & (US$ Million)
Table 135. Novo Nordisk Recent Development
Table 136. Piramal Healthcare Company Details
Table 137. Piramal Healthcare Business Overview
Table 138. Piramal Healthcare Oral Anti-diabetes Drugs Product
Table 139. Piramal Healthcare Revenue in Oral Anti-diabetes Drugs Business (2016-2021) & (US$ Million)
Table 140. Piramal Healthcare Recent Development
Table 141. Bayer Healthcare Company Details
Table 142. Bayer Healthcare Business Overview
Table 143. Bayer Healthcare Oral Anti-diabetes Drugs Product
Table 144. Bayer Healthcare Revenue in Oral Anti-diabetes Drugs Business (2016-2021) & (US$ Million)
Table 145. Bayer Healthcare Recent Development
Table 146. Dr. Reddy’s Laboratories Ltd Company Details
Table 147. Dr. Reddy’s Laboratories Ltd Business Overview
Table 148. Dr. Reddy’s Laboratories Ltd Oral Anti-diabetes Drugs Product
Table 149. Dr. Reddy’s Laboratories Ltd Revenue in Oral Anti-diabetes Drugs Business (2016-2021) & (US$ Million)
Table 150. Dr. Reddy’s Laboratories Ltd Recent Development
Table 151. Glenmark Pharmaceuticals Ltd Company Details
Table 152. Glenmark Pharmaceuticals Ltd Business Overview
Table 153. Glenmark Pharmaceuticals Ltd Oral Anti-diabetes Drugs Product
Table 154. Glenmark Pharmaceuticals Ltd Revenue in Oral Anti-diabetes Drugs Business (2016-2021) & (US$ Million)
Table 155. Glenmark Pharmaceuticals Ltd Recent Development
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oral Anti-diabetes Drugs Market Share by Type: 2020 VS 2027
Figure 2. Liquid Features
Figure 3. Capsule Features
Figure 4. Tablet Features
Figure 5. Global Oral Anti-diabetes Drugs Market Share by Distribution Channel: 2020 VS 2027
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Oral Anti-diabetes Drugs Report Years Considered
Figure 10. Global Oral Anti-diabetes Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Oral Anti-diabetes Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Oral Anti-diabetes Drugs Market Share by Regions: 2020 VS 2027
Figure 13. Global Oral Anti-diabetes Drugs Market Share by Regions (2022-2027)
Figure 14. Global Oral Anti-diabetes Drugs Market Share by Players in 2020
Figure 15. Global Top Oral Anti-diabetes Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Anti-diabetes Drugs as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Oral Anti-diabetes Drugs Revenue in 2020
Figure 17. Global Oral Anti-diabetes Drugs Revenue Market Share by Type (2016-2021)
Figure 18. Global Oral Anti-diabetes Drugs Revenue Market Share by Type (2022-2027)
Figure 19. North America Oral Anti-diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Oral Anti-diabetes Drugs Market Share by Type (2016-2027)
Figure 21. North America Oral Anti-diabetes Drugs Market Share by Distribution Channel (2016-2027)
Figure 22. North America Oral Anti-diabetes Drugs Market Share by Country (2016-2027)
Figure 23. United States Oral Anti-diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Oral Anti-diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Oral Anti-diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Oral Anti-diabetes Drugs Market Share by Type (2016-2027)
Figure 27. Europe Oral Anti-diabetes Drugs Market Share by Distribution Channel (2016-2027)
Figure 28. Europe Oral Anti-diabetes Drugs Market Share by Country (2016-2027)
Figure 29. Germany Oral Anti-diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Oral Anti-diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Oral Anti-diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Oral Anti-diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Oral Anti-diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Oral Anti-diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Oral Anti-diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Oral Anti-diabetes Drugs Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Oral Anti-diabetes Drugs Market Share by Distribution Channel (2016-2027)
Figure 38. Asia-Pacific Oral Anti-diabetes Drugs Market Share by Region (2016-2027)
Figure 39. China Oral Anti-diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Oral Anti-diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Oral Anti-diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Oral Anti-diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Oral Anti-diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Oral Anti-diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Oral Anti-diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Oral Anti-diabetes Drugs Market Share by Type (2016-2027)
Figure 47. Latin America Oral Anti-diabetes Drugs Market Share by Distribution Channel (2016-2027)
Figure 48. Latin America Oral Anti-diabetes Drugs Market Share by Country (2016-2027)
Figure 49. Mexico Oral Anti-diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Oral Anti-diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Oral Anti-diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Oral Anti-diabetes Drugs Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Oral Anti-diabetes Drugs Market Share by Distribution Channel (2016-2027)
Figure 54. Middle East & Africa Oral Anti-diabetes Drugs Market Share by Country (2016-2027)
Figure 55. Turkey Oral Anti-diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Oral Anti-diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Oral Anti-diabetes Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Sanofi Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2016-2021)
Figure 59. Eli Lilly Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2016-2021)
Figure 60. AstraZeneca plc Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2016-2021)
Figure 61. Astellas Pharma Inc Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2016-2021)
Figure 62. Johnson & Johnson (Janssen Pharmaceuticals) Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2016-2021)
Figure 63. Boehringer Ingelheim Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2016-2021)
Figure 64. Merck Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2016-2021)
Figure 65. Takeda Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2016-2021)
Figure 66. Bristol Myers Squibb Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2016-2021)
Figure 67. Novartis Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2016-2021)
Figure 68. Pfizer Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2016-2021)
Figure 69. Abbott Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2016-2021)
Figure 70. Biocon Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2016-2021)
Figure 71. Sunpharma Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2016-2021)
Figure 72. Novo Nordisk Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2016-2021)
Figure 73. Piramal Healthcare Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2016-2021)
Figure 74. Bayer Healthcare Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2016-2021)
Figure 75. Dr. Reddy’s Laboratories Ltd Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2016-2021)
Figure 76. Glenmark Pharmaceuticals Ltd Revenue Growth Rate in Oral Anti-diabetes Drugs Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed